Galmed Pharmaceuticals
GLMD
#11043
Rank
โ‚ฌ4.5 M
Marketcap
4,22ย โ‚ฌ
Share price
21.05%
Change (1 day)
417.51%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2026 (TTM): -11,05ย โ‚ฌ

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -11,73ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -1.285ย โ‚ฌ an increase over its 2016 EPS that were of -1.953ย โ‚ฌ.

EPS history for Galmed Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-11,05ย โ‚ฌ
2017-1.285ย โ‚ฌ-34.23%
2016-1.953ย โ‚ฌ56.84%
2015-1.245ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Evoke Pharma
EVOK
-2,29ย โ‚ฌ-80.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-0,97ย โ‚ฌ-91.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-0,68ย โ‚ฌ-94.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-5,76ย โ‚ฌ-50.85%๐Ÿ‡บ๐Ÿ‡ธ USA